HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationship of argyrophilic proteins of nucleolal organizer regions in Ki-67+ cells with clinical and morphological parameters in lung adenocarcinoma.

Abstract
Ninety-four lung adenocarcinoma samples obtained during surgeries were examined using a combination of immunohistochemical staining for Ki-67 antigen and silver nitrate staining for argyrophilic nucleolar organizer (Ag-NOR) proteins. In lung adenocarcinoma, we studied the correlation between the area of Ag-NOR proteins in Ki-67(+) cells and clinical and morphological TNM parameters: maximum tumor diameter (T) and stage of the disease and tumor differentiation degree (N). Survival of patients with small area of Ag-NOR proteins in Ki-67(+) cells was higher that in patients with great area of these proteins. The area of Ag-NOR proteins in Ki-67(+) cells is an independent prognostic factor in lung adenocarcinoma. The area of Ag-NOR proteins in Ki-67(+) cells correlates with clinical and morphological TNM parameters and survival of patients with lung adenocarcinoma.
AuthorsA F Lazarev, D S Kobyakov, A M Avdalyan, E L Lushnikova, L M Nepomnyashchikh
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 158 Issue 1 Pg. 145-9 (Nov 2014) ISSN: 1573-8221 [Electronic] United States
PMID25408525 (Publication Type: Journal Article)
Chemical References
  • Antigens, Nuclear
  • Biomarkers, Tumor
  • Ki-67 Antigen
  • nucleolar organizer region associated proteins
Topics
  • Adenocarcinoma (metabolism, mortality, pathology)
  • Adenocarcinoma of Lung
  • Adult
  • Aged
  • Antigens, Nuclear (metabolism)
  • Biomarkers, Tumor (metabolism)
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Ki-67 Antigen (metabolism)
  • Lung Neoplasms (metabolism, mortality, pathology)
  • Male
  • Middle Aged
  • Nucleolus Organizer Region (metabolism)
  • Proportional Hazards Models

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: